Efficacy and safety evaluation of Fanhdi®, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study

Corresponding Author

Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Autónoma University, Madrid, Spain

Correspondence

Víctor Jiménez-Yuste, Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain.

View original article

0 0 0 0 0 0 0

留言 (0)